Validation of the predictive value of modeled HCG residual production āPā in low-risk gestational trophoblastic neoplasia (GTN) patients treated in GOG-174 phase III trial.
Benoit You
No relevant relationships to disclose
Wei Deng
No relevant relationships to disclose
Amit M. Oza
No relevant relationships to disclose
Raymond Osborne
No relevant relationships to disclose